US Patent 7776814 Tubulysin conjugates
Patent 7776814 was granted and assigned to R&D-Biopharmaceuticals GmbH on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+145 characters)
Article
Patent abstract
The invention relates to novel tubulysin conjugates (e.g. of tubulysin A) and the use thereof in the treatment of cancer diseases.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07776814 Tubulysin conjugates US Patent 7776814 Tubulysin conjugates
Infobox
Patent Number
0777681400
Patent Number
777681400
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077768140
Date of Patent
August 17, 2010
0Patent Application Number
105207910
Date Filed
July 9, 2003
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077768140
Date of Patent
August 17, 2010
0Patent Application Number
105207910
Date Filed
July 9, 2003
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07776814 Tubulysin conjugates
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07776814
Date of patent
August 17, 2010
Patent application number
10520791
Date Filed
July 9, 2003
Patent primary examiner
Find more entities like US Patent 7776814 Tubulysin conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
